Development of Novel Monoclonal Antibodies for the, Analysis of Functional Sites in FGF-2

References

• Baird A., Scheubert D., Ling N., Guillemin R. Receptor-and heparin-binding domains of basic fibroblast growth factor. Proc. Naf'l. Acad. Sci. USA 1988; 85: 2324–2328
   PubMed Web of Science ®Google Scholar
• Bashkin P., Doctrow S., Klagsbrun M., Svahna C. M., Folkman J., Vlodavsky I. Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. Biochemistry 1989; 28: 1737–1743
   PubMed Web of Science ®Google Scholar
• Bikfalvi A., Klein S., Pintucci G., Rifkin D. B. Biological roles of fibroblast growth factor-2. Endocrine Reviews 1997; 18: 26–45
   PubMed Web of Science ®Google Scholar
• Bjercke R. J., Cook G., Rychlik N., Gjika H. B., Van Vunakis H., Langone J. J. Stereospeciafic monoclonal antibodies to nicotine and cotinine and their use in enzyme-linked immunosorbent assays. J. Immunol. Meth. 1986; 90: 203–213
   PubMedGoogle Scholar
• Cunningham S. A., Stephan C. C., Arrate M. P., Ayer K. G., Brock T. A. Identification of the extracellular domains of fit-1 that mediate ligand interactions. Biochem. Biophys. Res. Comm. 1997; 231: 596–599
   PubMed Web of Science ®Google Scholar
• Faham S., Hileman R. E., Fromm J. R., Linhardt R. J., Rees D. C. Heparin structure and interactions with basic fibroblast growth factor. Science 1996; 271: 1116–1120
   PubMed Web of Science ®Google Scholar
• Fannon M., Nugent M. A. Basic fibroblast growth factor binds its receptors, is internalized, and stimulates DNA synthesis in Balb/c 3T3 cells in the absence of heparan sulfate. J. Biol. Chew. 1996; 271: 17949–17956
   Google Scholar
• Fox J. C., Shanley J. R. Antisense inhibition of basic fibroblast growth factor induces apoptosis in vascular smooth muscle cells. J. Biol. Chem. 1996; 271: 12578–12584
   PubMed Web of Science ®Google Scholar
• Gospodarowicz D., Hirabayashi G., Giguere L., Tauber J. P. Factors controlling the proliferative rate, final cell density, and life span of bovine vascular smooth muscle cells in culture. J. Cell Biol. 1981; 89: 568–578
   PubMed Web of Science ®Google Scholar
• Gross J. L., Herblin W. F., Dusak B. A., Czerniak P., Diamond M. D., Sun T., Eidsvoog K., Dexter D. L., Yayon A. Effects of modulation of basic fibroblast growth factor on tumor growth in vivo. J. Nut'l. Cancer Inst. 1993; 85: 121–131
   PubMed Web of Science ®Google Scholar
• Hori A., Sasada R., Matsutani E., Naito K., Sakura Y., Fujita T., Kozai Y. Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor. Cancer Res. 1991; 51: 6180–6184
   PubMed Web of Science ®Google Scholar
• Kan M., Shi E. G., McKeehan W. L. Identification and assay of fibroblast growth factor receptors. Methods in Enzymology 1991; 198: 158–171
   PubMedGoogle Scholar
• Kohler G., Milstein C. Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion. European J. Immunol. 1976; 6: 511–519
   PubMed Web of Science ®Google Scholar
• Kogan T. P., Revelle B. M., Tapp S., Scott D., Beck P. A. Single amino acid residue can determine the ligand specificity of E-sclectin. J. Biol. Chem. 1995; 270: 14047–14055
   PubMed Web of Science ®Google Scholar
• Ku P.-T., D-Amore P. A. Regulation of basic fibroblast growth factor (FGF-2) gene and protein expression following its release from sublethally injured endothelial cells. J. Cell. Biochem. 1995; 58: 328–343
   PubMed Web of Science ®Google Scholar
• Matsuzaki K., Yoshitake Y., Matuo Y., Sasaki H., Nishikawa K. Monoclonal antibodies against heparin-binding growth factor II/basic fibroblast growth factor that block its biological activity: Invalidity of the antibodies for tumor angiogenesis. Proc. Nat'l. Acad. Sci. USA 1989; 86: 9911–9915
   PubMed Web of Science ®Google Scholar
• Mertens G., Cassiman J. J., Vanden Berghe H., Vermylen J., David G. Cell surface heparan sulfate proteoglycans from human vascular endothelial cells. Core protein characterization and antithrombin III binding properties. J. Biol. Chem. 1992; 267: 20435–20443
   PubMed Web of Science ®Google Scholar
• Owens G. K., Loeb A., Gordon D., Thompson M. M. Expression of smooth muscle-specific alpha-isoactin in cultured vascular smooth muscle cells: relationship between growth and cytodifferentation. J. Cell Biol. 1986; 102: 343–352
   PubMed Web of Science ®Google Scholar
• Presta M., Statuto M., Isacchi A., Caccia P., Pozzi A., Gualandris A., Rusnati M., Bergonzoni L., Sarmientos P. Structure-function relationship of basic fibroblast growth factor: Site-directed mutagenesis of a putative heparin-binding and receptor binding region. Biochem. Biophys. Res. Comm. 1992; 185: 1098–1107
   PubMed Web of Science ®Google Scholar
• Reilly T. M., Taylor D. S., Herblin W. F., Thoolen M. J., Chiu A. T., Watson D. W., Timmerman P. B. Monoclonal antibodies directed against basic fibroblast growth factor which inhibit its biological activity in vitro and in vivo. Biochem. Biophys. Res. Comm. 1989; 164: 736–743
   PubMed Web of Science ®Google Scholar
• Saksela O., Rifkin D. B. Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated protcolyticactivity. J. Cell Biol. 1990; 110: 767–775
   PubMed Web of Science ®Google Scholar
• Schweigerer L., Neufeld G., Friedman A. J., Fiddes J., Gospodarowicz D. Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth. Nature 1987; 325: 257–259
   PubMed Web of Science ®Google Scholar
• Springer B. A., Pantoliano M. W., Barbera F. A., Gunyuzlu P. L., Thompson L. D., Herblin W. F., Rosenfeld S. A., Book G. W. Identification and concerted function of two receptor binding surfaces on basic fibroblast growth factor required for mitogenesis. J. Biol. Chem. 1994; 269: 26879–26884
   PubMed Web of Science ®Google Scholar
• Thompson L. D., Pantoliano M. W., Springer B. A. Energetic characterization of the basic fibroblast growth factor-heparin interaction: Identification of the heparin binding domain. Biochemistry 1994; 33: 3831–3840
   PubMed Web of Science ®Google Scholar
• Vlodavsky I., Folkman J., Sullivan R., Fridman R., Ishai-Michaeli R., Sasse J., Klagsbrun M. Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. Proc. Nat'l. Acad. Sci. USA 1987; 84: 2292–2296
   PubMed Web of Science ®Google Scholar
• Wilkie A. O., Morriss-Kay G. M., Jones E. Y., Heath J. K. Functions of fibroblast growth factors and their receptors. Current Biol. 1995; 5: 500–507
   PubMedGoogle Scholar
• Yayon A., Aviezer D., Safran M., Gross J. L., Heldman Y., Cabilly S., Givol D., Katchalski-Katzir E. Isolation of peptides that inhibit binding of basic fibroblast growth factor to its receptor from a random phage-epitope library. Proc. Nat'l. Acad. Sci. USA 1993; 90: 10643–10647
   PubMed Web of Science ®Google Scholar